Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

European journal of neurology·2026
Same author

Correction: The association between amyloid-beta deposition on dual-task gait performance is partially moderated by cognitive functions in healthy older adults.

Scientific reports·2026
Same author

Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.

Annals of neurology·2026
Same author

Patterns of weariness-related symptoms in Parkinson's disease: impact of disease progression and levodopa treatment.

Clinical parkinsonism & related disorders·2026
Same author

The Effect of Nephrology Referral on CKD Outcomes in Israel.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Parkinson's disease in real life healthcare organization database: a medication-based algorithm.

BMC neurology·2026
Same journal

Global regional and national burden and trends of early-onset Parkinson's disease from 1990 to 2021.

NPJ Parkinson's disease·2026
Same journal

Local and global microstructural and functional thalamomotor connectivity alterations in Parkinson's disease following motor learning.

NPJ Parkinson's disease·2026
Same journal

A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National Cohort.

NPJ Parkinson's disease·2026
Same journal

Smartphone-derived digital motor measures to monitor progression in idiopathic REM sleep behavior disorder.

NPJ Parkinson's disease·2026
Same journal

Overexpression of phosphorylated and truncated α-Synuclein does not trigger Parkinsonian readouts in A53T-SNCA mice.

NPJ Parkinson's disease·2026
Same journal

Morbidity, mortality, facility placement and cost of deep brain stimulation for Parkinson's disease.

NPJ Parkinson's disease·2026
查看所有相关文章

相关实验视频

Updated: May 6, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K

使用计算方法优化帕金森病进展尺度.

Assaf Benesh1, Roy N Alcalay2,3,4, Anat Mirelman4,5

  • 1Blavatnik School of Computer Science and Artificial Intelligence, Tel Aviv University, Tel Aviv, Israel.

NPJ Parkinson's disease
|January 23, 2026
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种数据驱动的方法,以改善帕金森病 (PD) 尺度. 优化的体重更好地反映了疾病的严重程度,有可能提高帕金森病研究的临床试验效率.

更多相关视频

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K

相关实验视频

Last Updated: May 6, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K

科学领域:

  • 神经学 神经学
  • 临床试验 临床试验
  • 生物统计学 生物统计学

背景情况:

  • 帕金森病 (PD) 是一种复杂的神经疾病,具有多种运动和非运动症状.
  • 当前的临床量表,如运动障碍学会的帕金森病统一评级量表 (MDS-UPDRS),在评估疾病进展时,认为单项具有统一的重要性.
  • 这种假设可能无法准确地捕捉到PD进展的异质性质.

研究的目的:

  • 开发和验证一个数据驱动的方法,以优化在帕金森病研究中使用的临床尺度内的项目权重.
  • 提高总评分的准确性,反映潜在疾病的严重程度和进展.
  • 提高帕金森病临床试验的效率和统计能力.

主要方法:

  • 对来自帕金森病进展标记计划 (PPMI) 的纵向队列数据进行了回顾性观察分析.
  • 应用了新的方法来识别和加权那些最强烈地表明PD进展的项目和价值增量.
  • 优化权重使用持有PPMI数据和独立数据集 (BeaT-PD) 进行了验证.

主要成果:

  • 数据驱动的权重方法显著改善了总分数和临床进展之间的单调关系.
  • 不那么有信息的项目被减轻或排除,导致更敏感的进展措施.
  • 对独立数据集的验证证实了学习的权重的稳定性和通用性.

结论:

  • 优化临床量表的权衡提供了更准确的帕金森病严重程度和进展的测量.
  • 这种新的方法有可能增加临床试验中的统计能力并减少样本大小要求.
  • 实施数据驱动规模优化可以促进帕金森病的研究和治疗开发.